Table 2 Clinical features of the 14 patients with myopericytoma or myofibroma.
| Case | Sex/Age | Site | Duration (months) | Size (mm) | Follow up (months) |
|---|---|---|---|---|---|
| 1 | M/30 | Right hand, acral | – | 12 | – |
| 2 | F/13 | Right ankle | 24 | 25 | FOD 6 |
| 3 | F/13 | Left ankle | 5 | 30 | – |
| 4 | F/71 | Left ankle | – | 10 | FOD 1 |
| 5 | M/39 | Sole of foot | 24 | 11 | FOD 2 |
| 6 | M/60 | Left hand, dorsum | – | 8 | – |
| 7 | M/48 | Knee | 144 | 9 | – |
| 8 | F/35 | Left posterior neck | – | 10 | – |
| 9 | F/60 | Right upper arm | 36 | 12 | FOD 10 |
| 10 | M/30 | Left thumb, IP | 6 | 10 | FOD 1 |
| 11 | M/28 | Foot | 2 | 14 | FOD 56 |
| 12 | M/38 | Right ankle | – | 18 | FOD 2 |
| 13 | F/22 | Left finger, MCP | – | 18 | – |
| 14 | M/36 | Left knee | – | 45 | – |
Patient 2 had complete excision of residual tumour with same histological appearances 25 months after the initial biopsy and is free of disease 6 months later.
Patient 5 had complete excision of residual disease 4 months after biopsy and is free of disease two months later.
F, female; FOD, free of disease; IP, interphalangeal joint; M, male; MCP, metacarpophalangeal joint; RD, residual disease; –, unknown.